In today’s Pharmaceutical Executive Daily, Cognito Therapeutics and Nexcure secure new financing rounds to advance their pipelines, artificial intelligence and large language models reshape ...

Series C proceeds position Spectris for pivotal top-line data, regulatory submission, and launch planning ahead of a targeted ...

Eli Lilly launches Employer Connect, a new platform linking employers with benefit administrators and a pharmacy network to ...

She holds a PhD in organic chemistry from the University of Pennsylvania. In this Pharmaceutical Executive Academy discussion, Najat Khan, PhD, CEO of Recursion Pharmaceuticals and former chief data ...

AI-simulated HCP avatars enable unlimited, realistic practice with non-verbal cueing, reducing manager bandwidth constraints and reframing roleplay as a psychologically safe, scalable training ...

MFN pricing is still evolving as comments are due on the proposed rules for the globe and guard model. manufacturers have long had processes for providing price reductions to patients, including paper ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, ...

While regulatory alignment remains essential, operational urgency driving companies to AI adoption is equally profound. In ...

Under the four-year agreement, Blackstone Life Sciences will provide Teva with $400 million to fund ongoing and future ...

UCB secured worldwide exclusive rights to develop, manufacture, and commercialize ATG-201, including access to Antengene’s enabling manufacturing technology for this bispecific T-cell engager modality ...

In this Pharmaceutical Executive Academy discussion, Najat Khan, PhD, CEO of Recursion Pharmaceuticals and former chief data ...

Bavarian Nordic CEO Paul Chaplin will step down by the end of 2026 after overseeing the company’s transformation into a ...